Home » Newsletters » BioWorld Asia

BioWorld Asia

March 22, 2000

View Archived Issues

Other News To Note

GPC's Acquisition Of Mitotix Sees Transatlantic Firm Formed

More European Industry Attempts To Counter Anti-GM Prejudice

International Geneticists Identify Gene Causing Rare Dwarfism

Morphochem Acquires U.S.-Based Drug Screening Assay Developer

Genset Issues $10M In Shares To Abbott Laboratories

Vanguard, Wolfson Institute Expand Collaboration On CNS Treatments

Start-up Firm Files Patents On Gene-Profiling System

Promix Receives Venture Funds For Push In Rheumatoid Arthritis Area

Antisoma Prepares To Move Therex Into Phase IIa Breast Cancer Trials

NicOx Starts Phase I/II Trial Of Its Dermatology Drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...